DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

SPR Auto Technologies Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·8 Oct 2026, 5:44 am

SPR Auto Technologies

Shripiston Limited has informed the stock exchanges that it has obtained a certificate of compliance under SEBI’s Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has fulfilled all necessary requirements regarding its shareholding patterns and has successfully completed the process of updating its records with the Depositories.

This development is a routine administrative step for listed entities and does not indicate any change in the company's business operations. For investors, it serves as a confirmation that the company is in good standing with market regulators and that its shareholding data is accurate and up-to-date.

Investors should note that this is a non-event regarding the company's financial performance. The focus for the stock should remain on its core business metrics and operational progress. There is no immediate impact on the stock's price action from this specific regulatory update.